Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.
Department of Public Health, Institute of Tropical Medicine (ITM), Antwerp, Belgium.
J Antimicrob Chemother. 2024 Oct 1;79(10):2534-2542. doi: 10.1093/jac/dkae252.
To guide antibiotic stewardship interventions, understanding for what indications antibiotics are used is essential.
In rural Burkina Faso, we measured antibiotic dispensing across all healthcare providers. From October 2021 to February 2022, we surveyed patients in Nanoro district, Burkina Faso, following visits to health centres (3), pharmacies (2), informal medicine vendors (5) and inpatients in health centres. We estimated prevalence of antibiotic use and the proportion of Watch group antibiotics by provider type and by clinical presentation, assessing compliance with WHO's AWaRe Antibiotic Book. We estimated per capita antibiotic use by multiplying prevalence of antibiotic use, mean DDD per adult treatment course, and the rate of healthcare visits per 1000 inhabitants per day, estimated from a prior household survey.
Outpatient antibiotic use was more frequent after health centre visits (54.8%, of which 16.5% Watch, n = 1249) than after visits to pharmacies (26.2%, 16.3% Watch, n = 328) and informal medicine vendors (26.9%, 50.0% Watch, n = 349). The frequency of antibiotic use was highest for bronchitis (79.9% antibiotic use, of which 12.6% Watch), malaria (31.9%, 23.1% Watch), gastroenteritis (76.0%, 31.7% Watch), rhinopharyngitis (40.4%, 8.3% Watch) and undifferentiated fever (77.0%, 44.8% Watch). Compliance with WHO AWaRe guidance could have averted at least 68.4% of all Watch antibiotic use in outpatients at health centres. Community-wide, 2.9 DDD (95% CI 1.9-3.9) were used per 1000 adult inhabitants per day.
Most Watch antibiotic use at community level or primary care deviated from WHO guidance. Antibiotic stewardship should focus on key clinical presentations and include primary care and self-medication.
为了指导抗生素管理干预,了解抗生素的使用指征至关重要。
在布基纳法索农村地区,我们测量了所有医疗服务提供者的抗生素配药情况。2021 年 10 月至 2022 年 2 月,我们在布基纳法索纳诺罗区对卫生中心(3 个)、药店(2 个)、非正规药品供应商(5 个)和卫生中心住院患者进行了调查。我们根据世卫组织 AWaRe 抗生素手册,按提供者类型和临床表现,估计了抗生素使用的流行率和 Watch 组抗生素的比例。我们通过将抗生素使用的流行率、成人治疗疗程的平均日剂量(DDD)和每天每 1000 居民的医疗就诊率相乘,来估计人均抗生素使用量,这是从之前的家庭调查中估算得出的。
门诊抗生素使用在卫生中心就诊后更为常见(54.8%,其中 16.5% Watch,n=1249),而在药店就诊(26.2%,16.3% Watch,n=328)和非正规药品供应商就诊(26.9%,50.0% Watch,n=349)后则较少。使用抗生素最常见的病症是支气管炎(79.9%使用抗生素,其中 12.6% Watch)、疟疾(31.9%,23.1% Watch)、肠胃炎(76.0%,31.7% Watch)、鼻咽炎(40.4%,8.3% Watch)和未明确发热(77.0%,44.8% Watch)。如果遵守世卫组织 AWaRe 指导,至少可以避免卫生中心门诊中所有 Watch 类抗生素使用的 68.4%。在社区层面,每天每 1000 名成年居民使用 2.9 DDD(95%CI 1.9-3.9)抗生素。
社区层面或初级保健中大多数 Watch 类抗生素的使用与世卫组织的指导意见不符。抗生素管理应侧重于主要临床表现,并包括初级保健和自我用药。